ResearcherNYU Langone HealthNo recent work listed
Grace Oh
Matched on ORCID iD 0000-0002-1016-6376; OpenAlex author ID A5043527923. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 3 papers
Papers 3
- Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Co-author DOI 10.1038/s41467-023-36296-4↗
- Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Co-author DOI 10.1038/s41467-023-39680-2↗
- POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling. Co-author DOI 10.1172/jci165934↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Despoina Kalfakakou · 3 shared papers, 2023 · strength 0.41
- Paper POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STI… DOI 10.1172/jci165934↗
- Paper Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microen… DOI 10.1038/s41467-023-36296-4↗
- Paper Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma an… DOI 10.1038/s41467-023-39680-2↗
- Gregor Werba · 3 shared papers, 2023 · strength 0.41
- Paper POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STI… DOI 10.1172/jci165934↗
- Paper Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microen… DOI 10.1038/s41467-023-36296-4↗
- Paper Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma an… DOI 10.1038/s41467-023-39680-2↗
- Diane M. Simeone · 3 shared papers, 2023 · strength 0.41
- Paper POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STI… DOI 10.1172/jci165934↗
- Paper Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microen… DOI 10.1038/s41467-023-36296-4↗
- Paper Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma an… DOI 10.1038/s41467-023-39680-2↗
- Aristotelis Tsirigos · 2 shared papers, 2023 · strength 0.27
- Paper Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microen… DOI 10.1038/s41467-023-36296-4↗
- Paper Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma an… DOI 10.1038/s41467-023-39680-2↗
- Mara H. Sherman · 2 shared papers, 2023 · strength 0.27
- Paper Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microen… DOI 10.1038/s41467-023-36296-4↗
- Paper Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma an… DOI 10.1038/s41467-023-39680-2↗
- Tamas A. Gonda · 2 shared papers, 2023 · strength 0.27
- Paper Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microen… DOI 10.1038/s41467-023-36296-4↗
- Paper Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma an… DOI 10.1038/s41467-023-39680-2↗
- Paul E. Oberstein · 2 shared papers, 2023 · strength 0.27
- Paper Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microen… DOI 10.1038/s41467-023-36296-4↗
- Paper Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma an… DOI 10.1038/s41467-023-39680-2↗
- Talia Golan · 1 shared paper, 2023 · strength 0.14
- Lidong Wang · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.